Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ML-099
Cat. No.:
OB0225LY-0071
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
ML-099 is a targeted small molecule primarily designed to regulate signaling pathways associated with cell proliferation and survival.
Synonym:
496775-95-2; 2-[(2-Phenylethyl)thio]nicotinic acid; ML099; 2-(Phenethylthio)nicotinic acid; 2-(2-Phenylethylsulfanyl)pyridine-3-carboxylic acid; 2-(2-Phenylethylthio)-3-pyridinecarboxylic acid; 2-[(2-Phenylethyl)sulfanyl]pyridine-3-carboxylic acid
CAS No.:
496775-95-2
Compound CID:
888706
Formula:
C14H13NO2S
Formula Weight:
259.32
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ML-099 can be used for anti-tumor research.
Library Information
Targets:
GTPase superfamily
Receptors:
Cell division cycle 42; Rab2A; Rab7; Rac1; Ras
Pathways:
GPCR/G protein; Cell cycle/Checkpoint; MAPK
Plate Number:
AOCL-1
Plate Location:
h3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 192.81 mM
